Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIA
|
ENSG00000162599.11 | nuclear factor I A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_61559773_61559924 | NFIA | 5764 | 0.223106 | 0.84 | 4.6e-03 | Click! |
chr1_61369624_61369775 | NFIA | 38768 | 0.190777 | 0.84 | 4.8e-03 | Click! |
chr1_61087259_61087410 | NFIA | 243597 | 0.019157 | 0.80 | 1.0e-02 | Click! |
chr1_61369172_61369323 | NFIA | 38316 | 0.192444 | 0.78 | 1.2e-02 | Click! |
chr1_61567361_61567574 | NFIA | 13383 | 0.197481 | 0.78 | 1.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_36549458_36550287 | 0.98 |
TEKT2 |
tektin 2 (testicular) |
196 |
0.92 |
chr12_72667295_72667865 | 0.85 |
TRHDE |
thyrotropin-releasing hormone degrading enzyme |
317 |
0.85 |
chr5_121409447_121409998 | 0.78 |
LOX |
lysyl oxidase |
4258 |
0.27 |
chr6_75913619_75913933 | 0.76 |
COL12A1 |
collagen, type XII, alpha 1 |
1268 |
0.52 |
chr8_13371594_13371816 | 0.66 |
DLC1 |
deleted in liver cancer 1 |
569 |
0.79 |
chr12_78334342_78334902 | 0.63 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr6_28442401_28443147 | 0.62 |
ZSCAN23 |
zinc finger and SCAN domain containing 23 |
31530 |
0.13 |
chr4_187647302_187647732 | 0.62 |
FAT1 |
FAT atypical cadherin 1 |
359 |
0.93 |
chr18_43732416_43732901 | 0.61 |
C18orf25 |
chromosome 18 open reading frame 25 |
20861 |
0.15 |
chr2_158113918_158114875 | 0.60 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr4_111557687_111558154 | 0.58 |
PITX2 |
paired-like homeodomain 2 |
256 |
0.95 |
chr17_13505362_13505866 | 0.57 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
370 |
0.91 |
chr21_17567832_17567983 | 0.56 |
ENSG00000201025 |
. |
89182 |
0.1 |
chr11_19736431_19736825 | 0.55 |
NAV2 |
neuron navigator 2 |
1485 |
0.49 |
chr2_46928125_46928276 | 0.54 |
SOCS5 |
suppressor of cytokine signaling 5 |
1874 |
0.38 |
chr13_93879365_93880233 | 0.54 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr3_57529834_57530279 | 0.53 |
DNAH12 |
dynein, axonemal, heavy chain 12 |
12 |
0.96 |
chr5_92920900_92921226 | 0.53 |
ENSG00000237187 |
. |
291 |
0.9 |
chr1_98499845_98500395 | 0.53 |
ENSG00000225206 |
. |
10787 |
0.31 |
chr2_189839242_189839495 | 0.53 |
COL3A1 |
collagen, type III, alpha 1 |
269 |
0.92 |
chr7_22898137_22898380 | 0.51 |
ENSG00000221740 |
. |
2026 |
0.38 |
chr3_87038977_87039181 | 0.51 |
VGLL3 |
vestigial like 3 (Drosophila) |
773 |
0.79 |
chr7_18794250_18794418 | 0.50 |
ENSG00000222164 |
. |
53568 |
0.17 |
chr4_57276019_57276511 | 0.49 |
AC068620.1 |
Uncharacterized protein |
417 |
0.79 |
chr19_30719241_30719606 | 0.49 |
ZNF536 |
zinc finger protein 536 |
2 |
0.73 |
chr12_80663224_80663505 | 0.48 |
OTOGL |
otogelin-like |
60131 |
0.13 |
chr10_21462508_21463481 | 0.48 |
NEBL-AS1 |
NEBL antisense RNA 1 |
51 |
0.59 |
chr9_25677269_25678110 | 0.48 |
TUSC1 |
tumor suppressor candidate 1 |
1167 |
0.68 |
chr1_39980649_39981517 | 0.48 |
RP11-69E11.4 |
|
9465 |
0.14 |
chr15_47476270_47477144 | 0.47 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
chr7_134496657_134496808 | 0.47 |
CALD1 |
caldesmon 1 |
31903 |
0.23 |
chr19_4473895_4474732 | 0.47 |
HDGFRP2 |
Hepatoma-derived growth factor-related protein 2 |
576 |
0.53 |
chr5_172306134_172306575 | 0.46 |
ERGIC1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
25866 |
0.16 |
chr8_99960836_99961034 | 0.46 |
OSR2 |
odd-skipped related transciption factor 2 |
315 |
0.88 |
chr10_35102956_35103650 | 0.46 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr3_157154723_157155399 | 0.46 |
PTX3 |
pentraxin 3, long |
483 |
0.86 |
chr6_34210556_34210987 | 0.46 |
HMGA1 |
high mobility group AT-hook 1 |
4203 |
0.23 |
chr7_24966998_24967280 | 0.46 |
OSBPL3 |
oxysterol binding protein-like 3 |
9427 |
0.25 |
chr10_74854370_74854615 | 0.46 |
P4HA1 |
prolyl 4-hydroxylase, alpha polypeptide I |
2116 |
0.19 |
chr9_21590325_21590604 | 0.45 |
MIR31HG |
MIR31 host gene (non-protein coding) |
30796 |
0.16 |
chr7_151433344_151433930 | 0.45 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
237 |
0.95 |
chr9_684288_685148 | 0.45 |
RP11-130C19.3 |
|
837 |
0.67 |
chr1_217263352_217263815 | 0.45 |
ESRRG |
estrogen-related receptor gamma |
607 |
0.86 |
chr2_1746603_1747283 | 0.45 |
PXDN |
peroxidasin homolog (Drosophila) |
1271 |
0.58 |
chr20_9049976_9050220 | 0.44 |
PLCB4 |
phospholipase C, beta 4 |
350 |
0.89 |
chr3_114169976_114170457 | 0.44 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
3314 |
0.33 |
chr10_15411519_15412658 | 0.44 |
FAM171A1 |
family with sequence similarity 171, member A1 |
970 |
0.7 |
chr1_27126217_27126431 | 0.44 |
PIGV |
phosphatidylinositol glycan anchor biosynthesis, class V |
10905 |
0.11 |
chrX_17317155_17317306 | 0.44 |
ENSG00000238764 |
. |
58823 |
0.13 |
chr19_4391760_4392235 | 0.44 |
SH3GL1 |
SH3-domain GRB2-like 1 |
1390 |
0.22 |
chr7_17315289_17315760 | 0.43 |
AC003075.4 |
|
5403 |
0.27 |
chr19_41195400_41196566 | 0.43 |
NUMBL |
numb homolog (Drosophila)-like |
44 |
0.96 |
chr2_190042021_190042178 | 0.43 |
COL5A2 |
collagen, type V, alpha 2 |
2506 |
0.34 |
chr6_117086060_117086951 | 0.43 |
FAM162B |
family with sequence similarity 162, member B |
381 |
0.87 |
chr6_11196915_11197406 | 0.43 |
RP3-510L9.1 |
|
23475 |
0.18 |
chr15_96877000_96877175 | 0.43 |
ENSG00000222651 |
. |
597 |
0.47 |
chr7_54956069_54956673 | 0.43 |
ENSG00000252054 |
. |
22860 |
0.25 |
chr2_240230248_240230631 | 0.43 |
HDAC4 |
histone deacetylase 4 |
468 |
0.8 |
chr16_55513844_55514378 | 0.43 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
201 |
0.95 |
chr1_219523892_219524043 | 0.43 |
RP11-135J2.4 |
|
176664 |
0.03 |
chr11_122027725_122027876 | 0.43 |
ENSG00000207994 |
. |
4784 |
0.19 |
chr2_33361191_33361342 | 0.43 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
1542 |
0.54 |
chr8_122649996_122650341 | 0.43 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
1365 |
0.48 |
chrX_69699751_69699953 | 0.42 |
DLG3-AS1 |
DLG3 antisense RNA 1 |
24008 |
0.14 |
chr17_42187560_42187844 | 0.42 |
HDAC5 |
histone deacetylase 5 |
1007 |
0.34 |
chr6_46702576_46703631 | 0.42 |
PLA2G7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
24 |
0.97 |
chr19_13107353_13108160 | 0.42 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1104 |
0.3 |
chr7_7161828_7161979 | 0.42 |
ENSG00000201218 |
. |
19591 |
0.13 |
chr10_104060247_104060656 | 0.41 |
ENSG00000251989 |
. |
39464 |
0.11 |
chr5_63461313_63462499 | 0.41 |
RNF180 |
ring finger protein 180 |
83 |
0.99 |
chr7_129587119_129587270 | 0.41 |
UBE2H |
ubiquitin-conjugating enzyme E2H |
3973 |
0.15 |
chr4_86953999_86954560 | 0.41 |
RP13-514E23.1 |
|
19252 |
0.19 |
chr11_29969978_29970129 | 0.40 |
KCNA4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
68517 |
0.14 |
chr19_46110497_46110665 | 0.40 |
OPA3 |
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) |
5111 |
0.1 |
chr14_62279468_62280189 | 0.40 |
SNAPC1 |
small nuclear RNA activating complex, polypeptide 1, 43kDa |
50753 |
0.17 |
chr2_54684400_54684738 | 0.40 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
171 |
0.97 |
chr1_17867048_17867282 | 0.40 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
835 |
0.7 |
chr1_235795999_235796340 | 0.40 |
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4 |
17124 |
0.25 |
chr7_101045325_101045684 | 0.40 |
COL26A1 |
collagen, type XXVI, alpha 1 |
39382 |
0.14 |
chr1_179096167_179096689 | 0.40 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
15751 |
0.19 |
chr17_57564666_57564817 | 0.40 |
ENSG00000200889 |
. |
50119 |
0.12 |
chr19_50141513_50142109 | 0.39 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
1647 |
0.16 |
chr4_158143046_158143598 | 0.39 |
GRIA2 |
glutamate receptor, ionotropic, AMPA 2 |
504 |
0.84 |
chr1_170556205_170556361 | 0.39 |
RP11-576I22.2 |
|
54495 |
0.13 |
chr8_102184368_102184618 | 0.39 |
ZNF706 |
zinc finger protein 706 |
29392 |
0.19 |
chr3_188313614_188313904 | 0.39 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
13250 |
0.2 |
chr7_101543504_101543666 | 0.39 |
CTB-181H17.1 |
|
59811 |
0.12 |
chr5_121408801_121408984 | 0.38 |
LOX |
lysyl oxidase |
5088 |
0.26 |
chr15_39719310_39719510 | 0.38 |
RP11-624L4.1 |
|
14 |
0.99 |
chr7_127857654_127857944 | 0.38 |
ENSG00000207705 |
. |
9875 |
0.19 |
chr16_55513533_55513747 | 0.38 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
270 |
0.93 |
chr17_36621763_36622126 | 0.38 |
ARHGAP23 |
Rho GTPase activating protein 23 |
6236 |
0.17 |
chr19_56166514_56167932 | 0.38 |
U2AF2 |
U2 small nuclear RNA auxiliary factor 2 |
792 |
0.34 |
chr14_85995700_85996361 | 0.38 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
458 |
0.75 |
chr6_88875424_88876640 | 0.38 |
CNR1 |
cannabinoid receptor 1 (brain) |
46 |
0.99 |
chr1_2188708_2189057 | 0.38 |
SKI |
v-ski avian sarcoma viral oncogene homolog |
28748 |
0.11 |
chr9_22446798_22447485 | 0.38 |
DMRTA1 |
DMRT-like family A1 |
301 |
0.95 |
chr1_201915320_201915636 | 0.37 |
LMOD1 |
leiomodin 1 (smooth muscle) |
237 |
0.87 |
chr3_146231453_146231604 | 0.37 |
PLSCR1 |
phospholipid scramblase 1 |
15009 |
0.19 |
chr12_13351879_13352395 | 0.37 |
EMP1 |
epithelial membrane protein 1 |
2417 |
0.37 |
chr14_56792096_56792462 | 0.37 |
TMEM260 |
transmembrane protein 260 |
162793 |
0.04 |
chr4_157692546_157692809 | 0.37 |
RP11-154F14.2 |
|
69834 |
0.11 |
chr7_140016131_140016502 | 0.37 |
SLC37A3 |
solute carrier family 37, member 3 |
26973 |
0.14 |
chr11_101987791_101987942 | 0.37 |
YAP1 |
Yes-associated protein 1 |
4621 |
0.19 |
chr4_183474988_183475200 | 0.37 |
ENSG00000252343 |
. |
5282 |
0.29 |
chr1_80447922_80448073 | 0.37 |
ENSG00000266033 |
. |
347176 |
0.01 |
chr2_180726238_180726902 | 0.37 |
ZNF385B |
zinc finger protein 385B |
338 |
0.8 |
chr8_135469745_135470192 | 0.37 |
ZFAT |
zinc finger and AT hook domain containing |
52457 |
0.18 |
chr18_72509166_72509431 | 0.37 |
ZNF407 |
zinc finger protein 407 |
166322 |
0.04 |
chr14_80677438_80677725 | 0.37 |
DIO2 |
deiodinase, iodothyronine, type II |
76 |
0.65 |
chr1_68516408_68516606 | 0.37 |
DIRAS3 |
DIRAS family, GTP-binding RAS-like 3 |
47 |
0.98 |
chr1_110599214_110599542 | 0.37 |
RP4-773N10.4 |
|
1584 |
0.28 |
chr20_50182108_50182395 | 0.37 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
2881 |
0.38 |
chr15_51464550_51464723 | 0.36 |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
42785 |
0.14 |
chr3_147110503_147110750 | 0.36 |
ZIC1 |
Zic family member 1 |
1056 |
0.5 |
chr1_65005729_65006114 | 0.36 |
ENSG00000264470 |
. |
39609 |
0.19 |
chr13_44954706_44954857 | 0.36 |
SERP2 |
stress-associated endoplasmic reticulum protein family member 2 |
6803 |
0.28 |
chr16_65104457_65104608 | 0.36 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1584 |
0.58 |
chr19_47735595_47736220 | 0.36 |
BBC3 |
BCL2 binding component 3 |
116 |
0.95 |
chr16_73024055_73024442 | 0.36 |
ENSG00000221799 |
. |
5492 |
0.24 |
chr19_51226586_51226860 | 0.36 |
CLEC11A |
C-type lectin domain family 11, member A |
57 |
0.95 |
chr5_156973092_156973243 | 0.36 |
AC106801.1 |
|
19805 |
0.15 |
chr2_239895284_239895449 | 0.36 |
ENSG00000211566 |
. |
660 |
0.69 |
chr12_103969261_103969414 | 0.36 |
STAB2 |
stabilin 2 |
11714 |
0.19 |
chr4_95367292_95367585 | 0.36 |
PDLIM5 |
PDZ and LIM domain 5 |
5599 |
0.33 |
chr14_85998039_85998552 | 0.35 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
1723 |
0.42 |
chr3_64674138_64674393 | 0.35 |
ADAMTS9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
589 |
0.78 |
chr18_12253921_12254616 | 0.35 |
CIDEA |
cell death-inducing DFFA-like effector a |
50 |
0.98 |
chr16_88450130_88450579 | 0.35 |
ZNF469 |
zinc finger protein 469 |
43525 |
0.15 |
chr5_95070149_95070300 | 0.35 |
CTD-2154I11.2 |
|
2225 |
0.26 |
chr7_116169535_116169759 | 0.35 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
3300 |
0.2 |
chr8_58907686_58908288 | 0.35 |
FAM110B |
family with sequence similarity 110, member B |
874 |
0.76 |
chr16_54970178_54971110 | 0.35 |
IRX5 |
iroquois homeobox 5 |
4660 |
0.36 |
chr22_19973614_19974692 | 0.35 |
ARVCF |
armadillo repeat gene deleted in velocardiofacial syndrome |
463 |
0.71 |
chr17_58821066_58821723 | 0.35 |
ENSG00000252534 |
. |
5013 |
0.22 |
chr2_128453104_128453431 | 0.35 |
SFT2D3 |
SFT2 domain containing 3 |
5330 |
0.18 |
chr1_43415507_43415796 | 0.35 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
8849 |
0.19 |
chr14_33172715_33172866 | 0.35 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
32267 |
0.25 |
chr8_49343412_49343748 | 0.34 |
RP11-770E5.1 |
|
120547 |
0.06 |
chr2_48794075_48794240 | 0.34 |
STON1-GTF2A1L |
STON1-GTF2A1L readthrough |
2002 |
0.34 |
chr2_178110073_178110224 | 0.34 |
ENSG00000265396 |
. |
10590 |
0.11 |
chr22_46484431_46484684 | 0.34 |
ENSG00000266533 |
. |
2367 |
0.15 |
chr10_90710175_90710354 | 0.34 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
2266 |
0.25 |
chr6_86170308_86170602 | 0.34 |
NT5E |
5'-nucleotidase, ecto (CD73) |
10628 |
0.27 |
chr10_30138328_30138544 | 0.34 |
SVIL |
supervillin |
113703 |
0.06 |
chr3_192126971_192127690 | 0.34 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr19_13133635_13134622 | 0.34 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
677 |
0.52 |
chr7_55088250_55088401 | 0.34 |
EGFR |
epidermal growth factor receptor |
1514 |
0.55 |
chr6_3180329_3180508 | 0.34 |
TUBB2A |
tubulin, beta 2A class IIa |
22658 |
0.13 |
chr15_81072135_81072315 | 0.34 |
KIAA1199 |
KIAA1199 |
513 |
0.83 |
chr9_22117681_22117895 | 0.34 |
CDKN2B-AS1 |
CDKN2B antisense RNA 1 |
4111 |
0.31 |
chr8_8775544_8775695 | 0.34 |
ENSG00000200713 |
. |
22296 |
0.16 |
chr3_100711576_100712203 | 0.34 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
408 |
0.89 |
chr8_25901085_25901478 | 0.34 |
EBF2 |
early B-cell factor 2 |
1632 |
0.53 |
chr19_41725215_41725482 | 0.34 |
AXL |
AXL receptor tyrosine kinase |
208 |
0.89 |
chr13_76213824_76214088 | 0.33 |
LMO7 |
LIM domain 7 |
3497 |
0.21 |
chr9_17005029_17005234 | 0.33 |
ENSG00000241152 |
. |
48768 |
0.18 |
chr11_65203008_65203266 | 0.33 |
ENSG00000245532 |
. |
8792 |
0.12 |
chr4_27656815_27656966 | 0.33 |
ENSG00000222206 |
. |
431841 |
0.01 |
chr14_98101817_98101968 | 0.33 |
ENSG00000240730 |
. |
105382 |
0.08 |
chr4_87517094_87517245 | 0.33 |
PTPN13 |
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
323 |
0.88 |
chr3_58038544_58038725 | 0.33 |
FLNB |
filamin B, beta |
25422 |
0.22 |
chr10_24738869_24739102 | 0.33 |
KIAA1217 |
KIAA1217 |
623 |
0.8 |
chr14_69010738_69010917 | 0.33 |
CTD-2325P2.4 |
|
84335 |
0.09 |
chrX_8698839_8699470 | 0.33 |
KAL1 |
Kallmann syndrome 1 sequence |
1073 |
0.66 |
chr12_6335358_6335509 | 0.33 |
ENSG00000202318 |
. |
8188 |
0.18 |
chr4_24854129_24854280 | 0.33 |
SOD3 |
superoxide dismutase 3, extracellular |
57119 |
0.14 |
chr6_56111778_56112295 | 0.33 |
COL21A1 |
collagen, type XXI, alpha 1 |
199 |
0.97 |
chr1_1281505_1281949 | 0.33 |
DVL1 |
dishevelled segment polarity protein 1 |
2765 |
0.1 |
chr1_246948051_246948632 | 0.33 |
ENSG00000227953 |
. |
5585 |
0.17 |
chr12_91505056_91505217 | 0.33 |
LUM |
lumican |
472 |
0.85 |
chr19_11086301_11086459 | 0.33 |
SMARCA4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
8448 |
0.14 |
chr17_15360263_15360539 | 0.33 |
CDRT4 |
CMT1A duplicated region transcript 4 |
10524 |
0.19 |
chr13_50194281_50194827 | 0.33 |
ARL11 |
ADP-ribosylation factor-like 11 |
7881 |
0.21 |
chr17_15160744_15161217 | 0.33 |
RP11-849N15.1 |
|
3352 |
0.18 |
chr4_140808579_140808865 | 0.33 |
MAML3 |
mastermind-like 3 (Drosophila) |
2484 |
0.4 |
chr8_9953126_9953300 | 0.33 |
MSRA |
methionine sulfoxide reductase A |
24 |
0.98 |
chr5_124747464_124747729 | 0.33 |
ENSG00000222107 |
. |
60772 |
0.17 |
chr9_6788398_6788607 | 0.32 |
KDM4C |
lysine (K)-specific demethylase 4C |
30384 |
0.22 |
chr15_83870418_83870820 | 0.32 |
HDGFRP3 |
Hepatoma-derived growth factor-related protein 3 |
6151 |
0.19 |
chr20_50331847_50332076 | 0.32 |
ATP9A |
ATPase, class II, type 9A |
52906 |
0.15 |
chr5_67629922_67630135 | 0.32 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
41632 |
0.21 |
chr8_104385276_104385427 | 0.32 |
CTHRC1 |
collagen triple helix repeat containing 1 |
690 |
0.64 |
chr4_14113589_14113913 | 0.32 |
ENSG00000252092 |
. |
453500 |
0.01 |
chr9_132514889_132515259 | 0.32 |
PTGES |
prostaglandin E synthase |
252 |
0.91 |
chr1_103572231_103572444 | 0.32 |
COL11A1 |
collagen, type XI, alpha 1 |
1397 |
0.61 |
chr5_152931288_152931447 | 0.32 |
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
59635 |
0.16 |
chrX_151140603_151140985 | 0.32 |
GABRE |
gamma-aminobutyric acid (GABA) A receptor, epsilon |
2349 |
0.22 |
chr2_236404663_236404814 | 0.32 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
1987 |
0.38 |
chr2_102383129_102383280 | 0.32 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
30522 |
0.23 |
chr12_95779096_95779247 | 0.32 |
RP11-167N24.6 |
Uncharacterized protein |
4499 |
0.22 |
chr9_77344223_77344424 | 0.32 |
ENSG00000202217 |
. |
70488 |
0.11 |
chr2_45228184_45228926 | 0.32 |
SIX2 |
SIX homeobox 2 |
8014 |
0.26 |
chr14_61612550_61612795 | 0.32 |
PRKCH |
protein kinase C, eta |
41605 |
0.17 |
chr7_19155713_19156221 | 0.32 |
TWIST1 |
twist family bHLH transcription factor 1 |
1328 |
0.36 |
chr11_92261148_92261323 | 0.32 |
RP11-675M1.2 |
|
119893 |
0.06 |
chr6_8433732_8434221 | 0.32 |
SLC35B3 |
solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 |
1740 |
0.54 |
chr16_79605501_79605727 | 0.32 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
28185 |
0.25 |
chr1_229977308_229977459 | 0.32 |
URB2 |
URB2 ribosome biogenesis 2 homolog (S. cerevisiae) |
190789 |
0.03 |
chr4_174958599_174958750 | 0.32 |
FBXO8 |
F-box protein 8 |
246140 |
0.02 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.6 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.2 | 0.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 0.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.6 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 0.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.7 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.5 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.3 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 1.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.4 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 2.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.6 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.7 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.7 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.3 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.9 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.5 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.4 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.4 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.3 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.3 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.8 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.3 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0003307 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.4 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.6 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.2 | GO:0072273 | renal vesicle morphogenesis(GO:0072077) metanephric nephron morphogenesis(GO:0072273) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.1 | GO:0032292 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.2 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.0 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0036445 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 2.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.7 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.3 | GO:0061053 | somitogenesis(GO:0001756) somite development(GO:0061053) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0044256 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.0 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.1 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0015853 | purine nucleobase transport(GO:0006863) adenine transport(GO:0015853) |
0.0 | 0.4 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0098754 | detoxification(GO:0098754) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.4 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 1.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 1.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 7.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 2.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.0 | GO:0044216 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 1.1 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.8 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.6 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.6 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.6 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.4 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) potassium ion antiporter activity(GO:0022821) |
0.0 | 1.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 3.6 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 1.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 2.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 2.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.3 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |